19 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Discovery of Dual Inhibitors for Wild Type and D816V Mutant of c-KIT Kinase through Virtual and Biochemical Screening of Natural Products.

Sejong University
Structure-based de novo design and synthesis of aminothiazole-based p38 MAP kinase inhibitors.

Sejong University
Virtual screening and biochemical evaluation to identify new inhibitors of mammalian target of rapamycin (mTOR).

Sejong University
Discovery of potent inhibitors of receptor protein tyrosine phosphatase sigma through the structure-based virtual screening.

Sejong University
Discovery of MEK/PI3K dual inhibitor via structure-based virtual screening.

Sejong University
Structure-based virtual screening approach to identify novel classes of PTP1B inhibitors.

Sejong University
N-hydroxy-2-(naphthalene-2-ylsulfanyl)-acetamide, a novel hydroxamic acid-based inhibitor of aminopeptidase N and its anti-angiogenic activity.

Sejong University
Structure-based virtual screening approach to the discovery of p38 MAP kinase inhibitors.

Sejong University
Structure-based de novo design and biochemical evaluation of novel BRAF kinase inhibitors.

Sejong University
Identification of novel BRAF kinase inhibitors with structure-based virtual screening.

Sejong University
Structure-based virtual screening approach to the discovery of phosphoinositide 3-kinase alpha inhibitors.

Sejong University
Structure-based virtual screening approach to the discovery of novel inhibitors of factor-inhibiting HIF-1: identification of new chelating groups for the active-site ferrous ion.

Sejong University
Structure-based virtual screening approach to identify novel classes of Cdc25B phosphatase inhibitors.

Sejong University
Structure-based de novo design and biochemical evaluation of novel Cdc25 phosphatase inhibitors.

Sejong University
Identification of novel inhibitors of extracellular signal-regulated kinase 2 based on the structure-based virtual screening.

Sejong University
Discovery of novel Cdc25 phosphatase inhibitors with micromolar activity based on the structure-based virtual screening.

Sejong University
Discovery of novel PRL-3 inhibitors based on the structure-based virtual screening.

Sejong University
Fluorinated NSC as a Cdc25 inhibitor.

Sejong University
Application of Fragment-Based de Novo Design to the Discovery of Selective Picomolar Inhibitors of Glycogen Synthase Kinase-3 Beta.

Sejong University